Zimhi
- Product NDC
- 78670-140
- 11-digit product format
- 786700140
- Labeler code
- 78670
- Product ID
- 78670-140_98dc3cf1-2f05-4619-a6df-6c46c16e7af1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NALOXONE HYDROCHLORIDE
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; SUBCUTANEOUS
- Labeler
- USWM, LLC
- Application
- NDA212854
- Marketing category
- NDA
- Marketing start
- 2022-03-31
- Marketing end
- 0000-00-00
- Substance
- NALOXONE HYDROCHLORIDE
- Active strength
- 5 mg/.5mL
- Pharmacologic classes
- Opioid Antagonist [EPC], Opioid Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 78670-140 | ZIMHI (NALOXONE HYDROCHLORIDE) INJECTION, SOLUTION [USWM, LLC] | 7 | Legacy NDC | 20240621_52e49022-9172-4da3-ba83-5995cacca9fb.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 78670-140-02 | 78670014002 | 2 SYRINGE in 1 CARTON (78670-140-02) > .5 mL in 1 SYRINGE (78670-140-11) | 2 syringe | 2022-03-15 | 0000-00-00 | No | No | Current |